Abstract 043: Circulating Monocyte Gene Expression Profiles of Cardiac Remodeling and Incident Heart Failure: the Multi-Ethnic Study of Atherosclerosis

T Tess Peterson (Johns Hopkins University, Minneapolis, Minnesota, United States) Y Yongmei Liu (Division of Cardiology, Department of Medicine, School of Medicine, Duke University, Durham, NC, USA.) V Virginia Hahn (Johns Hopkins University, Baltimore, Maryland, United States) J Jerome Rotter (The Lundquist Institute, Torrance, California, United States) B Bharath Ambale-Venkatesh (Johns Hopkins University School of Medicine, Baltimore, Maryland, United States) V Vinithra Varadarajan (Johns Hopkins University, Baltimore, Maryland, United States) K Kurt Lohman (Duke University, Durham, North Carolina, United States) J Jingzhong Ding (WAKE FOREST UNIVERSITY SCHOOL, Winston Salem, North Carolina, United States) M Margaret Doyle (University of Vermont, Burlington, Vermont, United States) N Nels Olson (Larner College of Medicine at the University of Vermont, Burlington, Vermont, United States) P Peter Durda (Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, USA.) R Russell Tracy J Joao AC Lima (JOHNS HOPKINS UNIVERSITY, Timonium, Maryland, United States) K Katherine Wu W Wendy Post (JOHNS HOPKINS UNIVERSITY, Baltimore, Maryland, United States)

Abstract

Introduction: The role of circulating monocytes in non-ischemic cardiac remodeling and heart failure (HF) is complex and unclear, due in part to monocyte heterogeneity and plasticity. We assessed the hypothesis that monocyte gene expression profiles reflecting activation and tissue inflammation are associated with cardiac structure and function and incident adjudicated HF in the Multi-Ethnic Study of Atherosclerosis. Methods: Monocytes were isolated from peripheral blood, and RNA was quantified using an Illumina BeadChip microarray. Cardiac magnetic resonance was performed concurrently. We used multivariable linear regression to estimate cross-sectional associations between gene expression levels and cardiac structure and function and Cox regression to estimate associations with time to incident HF. Results: We studied 12,369 transcripts mapping to 9,430 genes among 813 participants (mean age 69±9 years; 50% female; 22% Black; 29% Hispanic). Independent of traditional risk factors, expression levels of 55 transcripts were associated with left ventricular (LV) ejection fraction, 1136 with LV strain, 16 with LV geometry, 1020 with myocardial interstitial fibrosis, and 483 with left atrial size (FDR<0.05). Enrichment analysis implicated T and B cell activation, cytokine production, phagocytosis, wound healing, oxidative stress, and cell migration. Expression levels of three genes—PCCB, MTCP1, and VIM—were associated with more than one cardiac metric as well as time to clinical HF ( n =45 events over a median follow-up of 7.7 years). Conclusion: These unique data support an association between monocyte-mediated immune processes and subclinical cardiac remodeling and incident HF in the absence of ischemic injury. Agnostically identified profiles were enriched for processes related to both pro-inflammatory and pro-resolving activated monocyte function and immunometabolism, as well as tissue migration and homeostasis. These insights may help generate hypotheses toward novel therapeutic targets for HF.

Article Details

Journal Circulation
Volume / Issue Vol. 151, Issue Suppl_1
Published March 11, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (15)

T

Tess Peterson

Johns Hopkins University, Minneapolis, Minnesota, United States

Y

Yongmei Liu

Division of Cardiology, Department of Medicine, School of Medicine, Duke University, Durham, NC, USA.

V

Virginia Hahn

Johns Hopkins University, Baltimore, Maryland, United States

J

Jerome Rotter

The Lundquist Institute, Torrance, California, United States

B

Bharath Ambale-Venkatesh

Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

V

Vinithra Varadarajan

Johns Hopkins University, Baltimore, Maryland, United States

K

Kurt Lohman

Duke University, Durham, North Carolina, United States

J

Jingzhong Ding

WAKE FOREST UNIVERSITY SCHOOL, Winston Salem, North Carolina, United States

M

Margaret Doyle

University of Vermont, Burlington, Vermont, United States

N

Nels Olson

Larner College of Medicine at the University of Vermont, Burlington, Vermont, United States

P

Peter Durda

Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, USA.

R

Russell Tracy

J

Joao AC Lima

JOHNS HOPKINS UNIVERSITY, Timonium, Maryland, United States

K

Katherine Wu

W

Wendy Post

JOHNS HOPKINS UNIVERSITY, Baltimore, Maryland, United States